Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology

PurposePrevious research has shown that bladder cancer has one of the highest incidences of developing a second primary malignancy. So, we designed this study to further examine this risk in light of race and histology.Patients and methodsUsing the surveillance, epidemiology, and end results (SEER)...

Full description

Bibliographic Details
Main Authors: Belaydi Othmane, Zhenglin Yi, Chunyu Zhang, Jinbo Chen, Xiongbing Zu, Benyi Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1036722/full
_version_ 1811224526617313280
author Belaydi Othmane
Belaydi Othmane
Zhenglin Yi
Zhenglin Yi
Chunyu Zhang
Chunyu Zhang
Jinbo Chen
Jinbo Chen
Xiongbing Zu
Xiongbing Zu
Benyi Fan
Benyi Fan
author_facet Belaydi Othmane
Belaydi Othmane
Zhenglin Yi
Zhenglin Yi
Chunyu Zhang
Chunyu Zhang
Jinbo Chen
Jinbo Chen
Xiongbing Zu
Xiongbing Zu
Benyi Fan
Benyi Fan
author_sort Belaydi Othmane
collection DOAJ
description PurposePrevious research has shown that bladder cancer has one of the highest incidences of developing a second primary malignancy. So, we designed this study to further examine this risk in light of race and histology.Patients and methodsUsing the surveillance, epidemiology, and end results (SEER) 18 registry, we retrospectively screened patients who had been diagnosed with bladder cancer between 2000 and 2018. We then tracked these survivors until a second primary cancer diagnosis, the conclusion of the trial, or their deaths. In addition to doing a competing risk analysis, we derived standardized incidence ratios (SIRs) and incidence rate ratios (IRRs) for SPMs by race and histology.ResultsA total of 162,335 patients with bladder cancer were included, and during follow-ups, a second primary cancer diagnosis was made in 31,746 of these patients. When the data were stratified by race, SIRs and IRRs for SPMs showed a significant difference: Asian/Pacific Islanders (APIs) had a more pronounced increase in SPMs (SIR: 2.15; p 0.05) than White and Black individuals who had an SIRs of 1.69 and 1.94, respectively; p 0.05. In terms of histology, the epithelial type was associated with an increase in SPMs across all three races, but more so in APIs (IRR: 3.51; 95% CI: 2.11–5.85; p 0.001).ConclusionWe found that race had an impact on both the type and risk of SPMs. Additionally, the likelihood of an SPM increases with the length of time between the two malignancies and the stage of the index malignancy.
first_indexed 2024-04-12T08:50:32Z
format Article
id doaj.art-4cc2f4be1a6b4b1b94ecc868adf3e6c6
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T08:50:32Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-4cc2f4be1a6b4b1b94ecc868adf3e6c62022-12-22T03:39:36ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-11-011010.3389/fpubh.2022.10367221036722Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histologyBelaydi Othmane0Belaydi Othmane1Zhenglin Yi2Zhenglin Yi3Chunyu Zhang4Chunyu Zhang5Jinbo Chen6Jinbo Chen7Xiongbing Zu8Xiongbing Zu9Benyi Fan10Benyi Fan11Department of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ChinaPurposePrevious research has shown that bladder cancer has one of the highest incidences of developing a second primary malignancy. So, we designed this study to further examine this risk in light of race and histology.Patients and methodsUsing the surveillance, epidemiology, and end results (SEER) 18 registry, we retrospectively screened patients who had been diagnosed with bladder cancer between 2000 and 2018. We then tracked these survivors until a second primary cancer diagnosis, the conclusion of the trial, or their deaths. In addition to doing a competing risk analysis, we derived standardized incidence ratios (SIRs) and incidence rate ratios (IRRs) for SPMs by race and histology.ResultsA total of 162,335 patients with bladder cancer were included, and during follow-ups, a second primary cancer diagnosis was made in 31,746 of these patients. When the data were stratified by race, SIRs and IRRs for SPMs showed a significant difference: Asian/Pacific Islanders (APIs) had a more pronounced increase in SPMs (SIR: 2.15; p 0.05) than White and Black individuals who had an SIRs of 1.69 and 1.94, respectively; p 0.05. In terms of histology, the epithelial type was associated with an increase in SPMs across all three races, but more so in APIs (IRR: 3.51; 95% CI: 2.11–5.85; p 0.001).ConclusionWe found that race had an impact on both the type and risk of SPMs. Additionally, the likelihood of an SPM increases with the length of time between the two malignancies and the stage of the index malignancy.https://www.frontiersin.org/articles/10.3389/fpubh.2022.1036722/fullsecond primary malignanciesbladder cancerSEER databasehistologyrace
spellingShingle Belaydi Othmane
Belaydi Othmane
Zhenglin Yi
Zhenglin Yi
Chunyu Zhang
Chunyu Zhang
Jinbo Chen
Jinbo Chen
Xiongbing Zu
Xiongbing Zu
Benyi Fan
Benyi Fan
Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
Frontiers in Public Health
second primary malignancies
bladder cancer
SEER database
histology
race
title Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
title_full Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
title_fullStr Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
title_full_unstemmed Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
title_short Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology
title_sort filling the gaps in the research about second primary malignancies after bladder cancer focus on race and histology
topic second primary malignancies
bladder cancer
SEER database
histology
race
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.1036722/full
work_keys_str_mv AT belaydiothmane fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT belaydiothmane fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT zhenglinyi fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT zhenglinyi fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT chunyuzhang fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT chunyuzhang fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT jinbochen fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT jinbochen fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT xiongbingzu fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT xiongbingzu fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT benyifan fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology
AT benyifan fillingthegapsintheresearchaboutsecondprimarymalignanciesafterbladdercancerfocusonraceandhistology